CN106722908A - A kind of promoting blood circulation lozenge of akebi and its production method - Google Patents
A kind of promoting blood circulation lozenge of akebi and its production method Download PDFInfo
- Publication number
- CN106722908A CN106722908A CN201510820489.1A CN201510820489A CN106722908A CN 106722908 A CN106722908 A CN 106722908A CN 201510820489 A CN201510820489 A CN 201510820489A CN 106722908 A CN106722908 A CN 106722908A
- Authority
- CN
- China
- Prior art keywords
- parts
- akebi
- lozenge
- blood circulation
- promoting blood
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 235000007756 Akebia quinata Nutrition 0.000 title claims abstract description 30
- 240000008027 Akebia quinata Species 0.000 title claims abstract description 30
- 239000007937 lozenge Substances 0.000 title claims abstract description 26
- 230000017531 blood circulation Effects 0.000 title claims abstract description 22
- 230000001737 promoting effect Effects 0.000 title claims abstract description 21
- 238000004519 manufacturing process Methods 0.000 title claims abstract description 13
- 239000003826 tablet Substances 0.000 claims abstract description 32
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 26
- 239000002994 raw material Substances 0.000 claims abstract description 21
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims abstract description 19
- 229920002472 Starch Polymers 0.000 claims abstract description 19
- 229940084030 carboxymethylcellulose calcium Drugs 0.000 claims abstract description 19
- 239000008103 glucose Substances 0.000 claims abstract description 19
- 239000008107 starch Substances 0.000 claims abstract description 19
- 235000019698 starch Nutrition 0.000 claims abstract description 19
- 241001061906 Caragana Species 0.000 claims abstract description 14
- 241000219764 Dolichos Species 0.000 claims abstract description 14
- 241001632576 Hyacinthus Species 0.000 claims abstract description 14
- 241001060310 Styracaceae Species 0.000 claims abstract description 14
- 235000001361 Styrax officinalis Nutrition 0.000 claims abstract description 14
- 235000019382 gum benzoic Nutrition 0.000 claims abstract description 14
- 241000234435 Lilium Species 0.000 claims abstract description 13
- 238000001035 drying Methods 0.000 claims abstract description 13
- 230000036541 health Effects 0.000 claims abstract description 8
- 239000000843 powder Substances 0.000 claims abstract description 8
- 238000002156 mixing Methods 0.000 claims abstract description 7
- 238000004806 packaging method and process Methods 0.000 claims abstract description 7
- 239000000706 filtrate Substances 0.000 claims description 12
- 238000000034 method Methods 0.000 claims description 10
- 230000008569 process Effects 0.000 claims description 7
- 239000012535 impurity Substances 0.000 claims description 6
- 239000011812 mixed powder Substances 0.000 claims description 6
- 238000001914 filtration Methods 0.000 claims description 3
- -1 packaging Substances 0.000 claims description 3
- 238000003825 pressing Methods 0.000 claims description 3
- 235000014347 soups Nutrition 0.000 claims description 3
- 238000001694 spray drying Methods 0.000 claims description 3
- 239000003643 water by type Substances 0.000 claims 2
- 239000003814 drug Substances 0.000 abstract description 7
- 230000000694 effects Effects 0.000 abstract description 7
- 239000004480 active ingredient Substances 0.000 abstract description 4
- 230000008901 benefit Effects 0.000 abstract description 4
- 231100000957 no side effect Toxicity 0.000 abstract description 3
- 230000001228 trophic effect Effects 0.000 abstract description 2
- 206010011224 Cough Diseases 0.000 description 5
- 239000000047 product Substances 0.000 description 5
- 206010047700 Vomiting Diseases 0.000 description 4
- 210000004369 blood Anatomy 0.000 description 4
- 239000008280 blood Substances 0.000 description 4
- 230000027939 micturition Effects 0.000 description 4
- 230000035807 sensation Effects 0.000 description 4
- 230000008673 vomiting Effects 0.000 description 4
- 206010012735 Diarrhoea Diseases 0.000 description 3
- 206010020772 Hypertension Diseases 0.000 description 3
- 206010030113 Oedema Diseases 0.000 description 3
- 208000002193 Pain Diseases 0.000 description 3
- 206010037660 Pyrexia Diseases 0.000 description 3
- 208000001848 dysentery Diseases 0.000 description 3
- 210000000867 larynx Anatomy 0.000 description 3
- 201000005630 leukorrhea Diseases 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 231100000862 numbness Toxicity 0.000 description 3
- 230000035935 pregnancy Effects 0.000 description 3
- 206010046901 vaginal discharge Diseases 0.000 description 3
- 206010013954 Dysphoria Diseases 0.000 description 2
- 206010036790 Productive cough Diseases 0.000 description 2
- 208000012287 Prolapse Diseases 0.000 description 2
- 206010046788 Uterine haemorrhage Diseases 0.000 description 2
- 210000000436 anus Anatomy 0.000 description 2
- 230000002950 deficient Effects 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 206010015037 epilepsy Diseases 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 208000035861 hematochezia Diseases 0.000 description 2
- 230000023597 hemostasis Effects 0.000 description 2
- 238000010926 purge Methods 0.000 description 2
- 210000000952 spleen Anatomy 0.000 description 2
- 208000024794 sputum Diseases 0.000 description 2
- 210000003802 sputum Anatomy 0.000 description 2
- 238000012795 verification Methods 0.000 description 2
- 208000004998 Abdominal Pain Diseases 0.000 description 1
- 201000000736 Amenorrhea Diseases 0.000 description 1
- 206010001928 Amenorrhoea Diseases 0.000 description 1
- 206010007247 Carbuncle Diseases 0.000 description 1
- 206010008190 Cerebrovascular accident Diseases 0.000 description 1
- 206010010071 Coma Diseases 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- 206010057315 Daydreaming Diseases 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- 206010019909 Hernia Diseases 0.000 description 1
- 208000031361 Hiccup Diseases 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 206010027514 Metrorrhagia Diseases 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 208000006011 Stroke Diseases 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 231100000540 amenorrhea Toxicity 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 230000003474 anti-emetic effect Effects 0.000 description 1
- 239000002111 antiemetic agent Substances 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 239000003212 astringent agent Substances 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 230000009045 body homeostasis Effects 0.000 description 1
- 239000006189 buccal tablet Substances 0.000 description 1
- 229940046011 buccal tablet Drugs 0.000 description 1
- 230000009172 bursting Effects 0.000 description 1
- 208000013116 chronic cough Diseases 0.000 description 1
- 208000019902 chronic diarrheal disease Diseases 0.000 description 1
- 239000007891 compressed tablet Substances 0.000 description 1
- 230000003750 conditioning effect Effects 0.000 description 1
- 239000007884 disintegrant Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 235000003599 food sweetener Nutrition 0.000 description 1
- 208000014617 hemorrhoid Diseases 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 208000004396 mastitis Diseases 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 210000000214 mouth Anatomy 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 201000005737 orchitis Diseases 0.000 description 1
- 206010033675 panniculitis Diseases 0.000 description 1
- 244000045947 parasite Species 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 210000002345 respiratory system Anatomy 0.000 description 1
- 210000000697 sensory organ Anatomy 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 210000004304 subcutaneous tissue Anatomy 0.000 description 1
- 229960004793 sucrose Drugs 0.000 description 1
- 239000003765 sweetening agent Substances 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 230000001256 tonic effect Effects 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 230000002936 tranquilizing effect Effects 0.000 description 1
- 230000008736 traumatic injury Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Abstract
A kind of promoting blood circulation lozenge of akebi and its production method.It is made up of raw materials such as akebi, acorn, lily, caulis bambusae in taenian, granatum, flower of hyacinth dolichos, storax, Chinese peashrub root, carboxymethylcellulose calcium, water soluble starch, glucose
,
Finished product is made by sorting, drying, decoction, mixing, powder processed, compressing tablet, packaging.Active ingredient in Chinese medicine is decocted and is made extract solution by the present invention, active ingredient is combined with lozenge, the nutriment in the Chinese medicine being effectively kept；By the proportioning of science, when product of the present invention is nourished human body, with mending without dry, trophic structure rationally, strengthens effect of human body constitution.The present invention has the advantages that health care, promoting blood circulation, pure natural, pollution-free, no side effectses, conveniently takes and nourish the body.
Description
Technical field：
The present invention relates to field of food health care, and in particular to a kind of promoting blood circulation lozenge of akebi and its production method.
Background technology
Buccal tablet refers to the compressed tablets for being contained in slow mechanism dissolved in oral cavity, and lozenge will have tempting color from inside to outside, so that the mouthfeel that user has had.Therefore, the figuration composition in lozenge, such as sugar, pigment additive often " a presumptuous guest usurps the role of the host " so that some by mistake lozenge is regarded as " sugar ".
At present, most of lozenge of in the market is all medicine, and most of medicines for being to treat Throat diseases, and narrow application range, therapeutic effect is general.And it is few using the utilization rate for being processed into health products containing chip technology, it is few to body-care effect, it is impossible to meet the market demand.
The content of the invention：
Integrate promoting blood circulation, pure natural, pollution-free, no side effectses it is an object of the invention to provide one kind, the akebi for conveniently taking and nourishing the body is promoting blood circulation lozenge and production method.
The object of the present invention is achieved like this.It is that the raw material matched somebody with somebody by following weight is made, akebi
15-30
Part, acorn
10-20
Part, lily
5-15
Part, caulis bambusae in taenian
3-15
Part, granatum
3-15
Part, flower of hyacinth dolichos
3-10
Part, storax
4-12
Part, Chinese peashrub root
6-9
Part, carboxymethylcellulose calcium
7-10
Part, water soluble starch
4-8
Part, glucose
10-15
Part.
Preparing the promoting blood circulation lozenge preferred weight ratio range of akebi of the present invention is, akebi
15-25
Part, acorn
10-15
Part, lily
5-12
Part, caulis bambusae in taenian
3-10
Part, granatum
3-10
Part, flower of hyacinth dolichos
3-8
Part, storax
4-10
Part, Chinese peashrub root
6-8
Part, carboxymethylcellulose calcium
7-9
Part, water soluble starch
4-7
Part, glucose
10-14
Part.
Preparing the promoting blood circulation lozenge best weight ratio scope of akebi of the present invention is, akebi
20
Part, acorn
12
Part, lily
10
Part, caulis bambusae in taenian
8
Part, granatum
8
Part, flower of hyacinth dolichos
5
Part, storax
8
Part, Chinese peashrub root
7
Part, carboxymethylcellulose calcium
8
Part, water soluble starch
6
Part, glucose
12
Part.
Above-mentioned each component is made the production method of the promoting blood circulation lozenge of akebi of the present invention, technical process is：Sorting, drying, decoction, mixing, powder processed, compressing tablet, packaging, concrete operation method follow these steps to successively：
A
, sorting, by raw material weight proportioning of soup processed, select that to meet the akebi of national health and quality standard, acorn, lily, caulis bambusae in taenian, granatum, flower of hyacinth dolichos, storax, Chinese peashrub root, carboxymethylcellulose calcium, water soluble starch, glucose feed standby；
B
, drying, in addition to carboxymethylcellulose calcium, water soluble starch, glucose, other raw materials are cut into block or sheet and are placed in desiccation in drying baker respectively, and temperature control exists
80-100
DEG C, the time
45
Minute, raw material moisture is evaporated to water content
18%
, compressing tablet；
C
, decoct, by above-mentioned ratio of weight and number, decocted during the raw material addition after drying is put into decocting device
2
It is secondary, add for the first time
7
Times water is decocted
1.5
Hour, second frame
5
Times water is decocted
1
Hour, filtrate is extracted in filtering respectively, will filtrate merging twice, the secondary filter dregs of a decoction and impurity, prepared extract solution；
D
, mixing, by above-mentioned ratio of weight and number, carboxymethylcellulose calcium, water soluble starch, glucose will be added to be sufficiently mixed uniformly in extract solution, prepared mixed liquor；
E
, powder processed, the filtrate of above-mentioned mixed liquor is cooled to room temperature, filtrate is made mixed powder using spray drying process, it is standby；
F
, compressing tablet, by above-mentioned mixed powder remove production process in generation impurity, then using the mode and ultraviolet compressing tablet mode compressing tablet for radiating compressing tablet；Tablet press machine direct tablet compressing is utilized after compressing tablet；
G
, packaging, by the good tablet of above-mentioned pressing according to specification for sale pack.
With lozenge be combined the traditional Chinese medicine ingredients for having good tonic effect to human body by the present invention, there is more preferable assimilation effect compared to existing lozenge, it is convenient for people to usually take, conditioning health, increase metabolism balance in vivo, regulation human body homeostasis is softer, and lifting constitution is gentler, effective for a long time can increase human body power and work endurance.
Active ingredient in Chinese medicine is decocted and is made extract solution by the present invention, active ingredient is combined with lozenge, the nutriment in the Chinese medicine being effectively kept；By the proportioning of science, when product of the present invention is nourished human body, with mending without dry, trophic structure rationally, strengthens effect of human body constitution.
In inventive formulation, akebi purging intense heat water-filling is promoting blood circulation；Hot urination is controlled, stranguria with turbid discharge, oedema is irritable feverish sensation in chest, larynx numbness pharyngalgia, inflexible pain all over, women's Amenorrhea, alactation；Acorn convergence is solid de-；Hemostasis；Removing toxic substances；Main dysentery；Have blood in stool；Hemorrhoid blood；Prolapse of the anus；Children's hernia；The long not mastitis of bursting of sore carbuncle；Orchitis；Lily Yin nourishing and lung moistening, clearing away the heart fire and tranquillizing；For yin chronic cough, blood-stained sputum, dysphoria palpitates with fear, insomnia and dreamful sleep is absent-minded；Caulis bambusae in taenian heat-clearing, cool blood, resolving sputum, antiemetic；Dysphoria with smothery sensation vomiting, hiccup are controlled, the hot cough and asthma of phlegm is spitted blood, and bleeding from five sense organs or subcutaneous tissue, uterine bleeding, vomiting during early pregnancy, a word used in place name is moved, frightened epilepsy；Granatum relieving diarrhea with astringents, hemostasis, expelling parasite；For chronic diarrhea, protracted dysentery is had blood in stool, prolapse of the anus, uterine bleeding, leukorrhea, abdominal pain due to enterositosis；Flower of hyacinth dolichos strengthening the spleen and stomach, dampness elimination of relieving summer heat；Control dysentery, diarrhea, leukorrhea with reddish discharge；Storax is opened surreptitiously, wards off dirty, analgesic；For apoplexy coma due to blocking of the respiratory system, suddenly faint, chest and abdomen crymodynia, frightened epilepsy；Chinese peashrub root clearing lung-heat benefit spleen, blood circulation and channel invigorating, governance wasting labor heat, cough, hypertension, women leukorrhea, metrorrhagia, arthragra, traumatic injury.
The present invention is summarized and perfect in taking and clinical verification by many cases patient, constantly, and recipe ratio is more complete, determined curative effect, to hot urination, the main disease such as stranguria with turbid discharge：Degree difference serves promoting blood circulation, the effect of purging intense heat water-filling, has the advantages that health care, promoting blood circulation, pure natural, pollution-free, no side effectses.
The present invention is through two groups of clinical verifications
,
One of which takes lozenge of the present invention for treatment group, takes once a day,
7
It is a course for the treatment of, and another group of control is taken " Amway ", taken once a day,
7
It is a course for the treatment of, per group selection outpatient
200
Example, wherein man
100
Example, female
100
Example, measures the big age
79
Year, minimal ages
25
In year, clinical manifestation is hot urination, stranguria with turbid discharge, oedema, irritable feverish sensation in chest, larynx numbness pharyngalgia, inflexible pain all over, deficient labor heat, cough, hypertension, and vomiting during early pregnancy, table one is to take the contrasting data after a course for the treatment of：
Table
1
Front and rear two groups of courses for the treatment of are taken to compare
(
Unit
:
People
)
There were significant differences for treatment group and control group, it will thus be seen that present invention application clinically has significant curative effect.
Technological advantage of the invention is：
1
, selection raw material and scientific formulation, production technology is advanced, and it is good that its product produces taste, convenient storage；
2
, in product without harmful components such as preservatives, keep nourishing and nutrition of the raw material to human body, be easily absorbed by the body；
3
, raw material sources extensively, plus process line is short, the manufacture of product easy processing.
Specific embodiment
With reference to specific embodiment, the present invention is further illustrated
Embodiment
1
：Suitable for hot urination, stranguria with turbid discharge, the crowd of oedema
The promoting blood circulation lozenge of akebi of the present invention is prepared to be made up of following component raw material（Consumption is weight portion）, akebi
15-30
Part, acorn
10-20
Part, lily
5-15
Part, caulis bambusae in taenian
3-15
Part, granatum
3-15
Part, flower of hyacinth dolichos
3-10
Part, storax
4-12
Part, Chinese peashrub root
6-9
Part, carboxymethylcellulose calcium
7-10
Part, water soluble starch
4-8
Part, glucose
10-15
Part.
Embodiment
2
：Suitable for irritable feverish sensation in chest, larynx numbness pharyngalgia, inflexible pain all over, the crowd of deficient labor heat
Preparing the promoting blood circulation lozenge preferred weight ratio range of akebi of the present invention is：Akebi
15-25
Part, acorn
10-15
Part, lily
5-12
Part, caulis bambusae in taenian
3-10
Part, granatum
3-10
Part, flower of hyacinth dolichos
3-8
Part, storax
4-10
Part, Chinese peashrub root
6-8
Part, carboxymethylcellulose calcium
7-9
Part, water soluble starch
4-7
Part, glucose
10-14
Part.
Embodiment
3
：Suitable for cough, hypertension, the crowd of vomiting during early pregnancy
Preparing the promoting blood circulation lozenge best weight ratio scope of akebi of the present invention is, akebi
20
Part, acorn
12
Part, lily
10
Part, caulis bambusae in taenian
8
Part, granatum
8
Part, flower of hyacinth dolichos
5
Part, storax
8
Part, Chinese peashrub root
7
Part, carboxymethylcellulose calcium
8
Part, water soluble starch
6
Part, glucose
12
Part.
Embodiment
4
Above-mentioned each component is made the production method of the promoting blood circulation lozenge of akebi of the present invention, technical process is：Sorting, drying, decoction, mixing, powder processed, compressing tablet, packaging, concrete operation method follow these steps to successively：
A
, sorting, by raw material weight proportioning of soup processed, select that to meet the akebi of national health and quality standard, acorn, lily, caulis bambusae in taenian, granatum, flower of hyacinth dolichos, storax, Chinese peashrub root, carboxymethylcellulose calcium, water soluble starch, glucose feed standby；
B
, drying, in addition to carboxymethylcellulose calcium, water soluble starch, glucose, other raw materials are cut into block or sheet and are placed in desiccation in drying baker respectively, and temperature control exists
80-100
DEG C, the time
45
Minute, raw material moisture is evaporated to water content
18%
, compressing tablet；
C
, decoct, by above-mentioned ratio of weight and number, decocted during the raw material addition after drying is put into decocting device
2
It is secondary, add for the first time
7
Times water is decocted
1.5
Hour, second frame
5
Times water is decocted
1
Hour, filtrate is extracted in filtering respectively, will filtrate merging twice, the secondary filter dregs of a decoction and impurity, prepared extract solution；
D
, mixing, by above-mentioned ratio of weight and number, carboxymethylcellulose calcium, water soluble starch, glucose will be added to be sufficiently mixed uniformly in extract solution, prepared mixed liquor；
E
, powder processed, the filtrate of above-mentioned mixed liquor is cooled to room temperature, filtrate is made mixed powder using spray drying process, it is standby；
F
, compressing tablet, by above-mentioned mixed powder remove production process in generation impurity, then using the mode and ultraviolet compressing tablet mode compressing tablet for radiating compressing tablet；Tablet press machine direct tablet compressing is utilized after compressing tablet；
G
, packaging, by the good tablet of above-mentioned pressing according to specification for sale pack.
Embodiment
2
If adding appropriate disintegrant such as in the prescription of lozenge
CMS-Na
Improve and contain tablet stability, or add the mediation mouthfeel such as cane sugar powder, mannitol, sorbierite, various sweeteners, essence.
Claims (4)
1. the promoting blood circulation lozenge of a kind of akebi, it is characterised in that：It is that the raw material matched by following weight is made, akebi 15-30 parts, acorn 10-20 parts, lily 5-15 parts, caulis bambusae in taenian 3-15 parts, granatum 3-15 parts, flower of hyacinth dolichos 3-10 parts, storax 4-12 parts, Chinese peashrub root 6-9 parts, carboxymethylcellulose calcium 7-10 parts, water soluble starch 4-8 parts, glucose 10-15 parts.
2. the promoting blood circulation lozenge of a kind of akebi according to claim 1, it is characterised in that：The weight proportion of wherein various raw materials is, akebi 15-25 parts, acorn 10-15 parts, lily 5-12 parts, caulis bambusae in taenian 3-10 parts, granatum 3-10 parts, flower of hyacinth dolichos 3-8 parts, storax 4-10 parts, Chinese peashrub root 6-8 parts, carboxymethylcellulose calcium 7-9 parts, water soluble starch 4-7 parts, glucose 10-14 parts.
3. the promoting blood circulation lozenge of a kind of akebi according to claim 1, it is characterised in that：The weight proportion of wherein various raw materials is, 20 parts of akebi, 12 parts of acorn, 10 parts of lily, 8 parts of caulis bambusae in taenian, 8 parts of granatum, 5 parts of flower of hyacinth dolichos, 8 parts of storax, 7 parts of Chinese peashrub root, 8 parts of carboxymethylcellulose calcium, 6 parts of water soluble starch, 12 parts of glucose.
4. the production method of the promoting blood circulation lozenge of akebi according to claim 1-3, it is characterised in that：Technical process is：Sorting, drying, decoction, mixing, powder processed, compressing tablet, packaging, concrete operation method follow these steps to successively：
A, sorting, by raw material weight proportioning of soup processed, select that to meet the akebi of national health and quality standard, acorn, lily, caulis bambusae in taenian, granatum, flower of hyacinth dolichos, storax, Chinese peashrub root, carboxymethylcellulose calcium, water soluble starch, glucose feed standby；
B, drying, in addition to carboxymethylcellulose calcium, water soluble starch, glucose, other raw materials are cut into block or sheet and are placed in desiccation in drying baker respectively, and temperature control 45 minutes time, makes raw material moisture be evaporated to water content 18%, compressing tablet at 80-100 DEG C；
C, decoction, by above-mentioned ratio of weight and number, decocted 2 times during the raw material addition after drying is put into decocting device, for the first time plus 7 times of waters are decocted 1.5 hours, second frame, 5 times of waters are decocted 1 hour, and filtrate is extracted in filtering respectively, filtrate will be merged twice, the secondary filter dregs of a decoction and impurity, are obtained extract solution；
D, mixing, by above-mentioned ratio of weight and number, carboxymethylcellulose calcium, water soluble starch, glucose will be added to be sufficiently mixed uniformly in extract solution, prepared mixed liquor；
E, powder processed, the filtrate of above-mentioned mixed liquor is cooled to room temperature, filtrate is made mixed powder using spray drying process, it is standby；
F, compressing tablet, the impurity that above-mentioned mixed powder is removed the generation in production process, then using the mode and ultraviolet compressing tablet mode compressing tablet for radiating compressing tablet；Tablet press machine direct tablet compressing is utilized after compressing tablet；
G, packaging, by the good tablet of above-mentioned pressing according to specification for sale pack.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510820489.1A CN106722908A (en) | 2015-11-24 | 2015-11-24 | A kind of promoting blood circulation lozenge of akebi and its production method |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510820489.1A CN106722908A (en) | 2015-11-24 | 2015-11-24 | A kind of promoting blood circulation lozenge of akebi and its production method |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN106722908A true CN106722908A (en) | 2017-05-31 |
Family
ID=58963181
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201510820489.1A Pending CN106722908A (en) | 2015-11-24 | 2015-11-24 | A kind of promoting blood circulation lozenge of akebi and its production method |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN106722908A (en) |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101708229A (en) * | 2009-12-15 | 2010-05-19 | 湖北香连药业有限责任公司 | Oral tablet and preparation method thereof |
| CN101829212A (en) * | 2010-05-19 | 2010-09-15 | 北京联合大学生物化学工程学院 | Buccal tablet and preparation method thereof |
-
2015
- 2015-11-24 CN CN201510820489.1A patent/CN106722908A/en active Pending
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101708229A (en) * | 2009-12-15 | 2010-05-19 | 湖北香连药业有限责任公司 | Oral tablet and preparation method thereof |
| CN101829212A (en) * | 2010-05-19 | 2010-09-15 | 北京联合大学生物化学工程学院 | Buccal tablet and preparation method thereof |
Non-Patent Citations (1)
| Title |
|---|
| 张显臣等: "《名老中医张显臣60年中药应用经验》", 28 February 2014, 山西科学技术出版社 * |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN104888007A (en) | Ferment mouthrinse for treating dental ulcer and preparation method thereof | |
| CN106722908A (en) | A kind of promoting blood circulation lozenge of akebi and its production method | |
| CN106728997A (en) | A kind of eleusine indica heat-clearing lozenge and its production method | |
| CN106722898A (en) | A kind of Fructus Corni tonifies the liver and kidney lozenge and its production method | |
| CN106728854A (en) | One kind the thorn clearing heat and detoxicating lozenge of spinach and its production method | |
| CN106729196A (en) | A kind of granatum relieving diarrhea with astringents lozenge and its production method | |
| CN106722910A (en) | Yi Zhong Mango benefit stomach lozenge and its production method | |
| CN106722903A (en) | A kind of radix cynanchi atrati clearing heat and cooling blood lozenge and its production method | |
| CN106722904A (en) | A kind of shrub lespedeza moistening lung and clearing heat lozenge and its production method | |
| CN106729171A (en) | A kind of barley strengthening the spleen and stomach lozenge and its production method | |
| CN106722175A (en) | A kind of clearing heat and detoxicating lozenge of senna and its production method | |
| CN106728499A (en) | A kind of winter creeper is stimulated the circulation of the blood and cause the muscles and joints to relax lozenge and its production method | |
| CN106722900A (en) | A kind of malt helps digestion and middle lozenge and its production method | |
| CN106728497A (en) | A kind of Herba seu Radix Amaranrhi (Radix Seu Herba Amaranthi Spinosi) removing toxic substances lozenge and its production method | |
| CN106728111A (en) | A kind of calabash blood-stasis-dissipating blood-circulation-promoting lozenge and its production method | |
| CN106728560A (en) | A kind of white mountain azalea and blood lozenge and its production method | |
| CN106728463A (en) | A kind of cloves temperature taste lozenge and its production method | |
| CN106729293A (en) | A kind of clearing heat and detoxicating lozenge of mung bean and its production method | |
| CN106728885A (en) | A kind of wheat dry measure used in former times preventing phlegm from forming and stopping coughing lozenge and its production method | |
| CN106722433A (en) | Yi Zhong Mango reinforcing stomach reg fluid lozenges and its production method | |
| CN106728993A (en) | A kind of willowleaf spiraea herb and root nourishing blood and tranquilization lozenge and its production method | |
| CN106728932A (en) | A kind of juice of Japanese banana heat-clearing lozenge and its production method | |
| CN106722905A (en) | A kind of Flos clerodendri japonici is calmed the nerves lozenge and its production method | |
| CN106728462A (en) | A kind of fragrant plant mentioned in ancient texts heat-clearing lozenge and its production method | |
| CN106729292A (en) | A kind of teasel root filling liver kidney lozenge and its production method |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20170531 |
|
| WD01 | Invention patent application deemed withdrawn after publication |